Comprehensive Clinical Laboratory report for a 66-year-old patient

Laboratory Results:

CRP: 29.9 mg/L; RF: 13.91 IU/ml; Uric acid: 0.427 mmol/L; RBC: 4.53 x10^6/μL; Hb: 14.03 g/dl; HCT: 42.80 %; MCV: 94.40 fL; MCH: 31.0 pg; MCHC: 32.8 g/dl; RDW: 15.4 %; Platelets: 141 x10^3/μL; WBC: 3.9 x10^3/μL; Neutrophil %: 29.2 %: Lymphocytes %: 54.5 %; Monocytes %: 7.2 %; Eosinophil %: 8.7 %; Neutrophil Abs Count: 1.1 x10^3/μL; Lymphocytes Abs Count: 2.1 x10^3/μL; Monocytes Abs Count: 0.3 x10^3/μL;

Interpretation

Part 1

Laboratory results show an active inflammation + immune system abnormality but not a classic bacterial infection pattern (because WBC and neutrophils are low)

The likely diagnosis considerations are: 1) Viral infection (very plausible) because of high CRP (can occur in severe viral illness), low WBC + neutropenia and relative lymphocytosis; 2) Autoimmune /inflammatory disease such as rheumatologic conditions (even with negative RF) Vasculitis or connective tissue disease especially if symptoms like: Joint pain, Fatigue, Fever are present; 3) Bone marrow suppression / hematologic issue suggested by: low WBC, low neutrophils, low-normal platelets, viral suppression and early hematologic disorders could be the causes. 4) Allergic / parasitic component due to eosinophilia. Correlation could be made with allergies or medications.

The most alarming results are Neutropenia (ANC 1.1) showing an increased infection risk and high CRP confirming a significant underlying process.

Combination of these two factors may require prompt clinical evaluation.

Doctor should consider the following:

•     Repeat CBC (to confirm trends)
•     Infection workup (viral panels, cultures)
•     Autoimmune screening (ANA, ESR, etc.)
•     Medication review (drug-induced cytopenias)
•     Possibly bone marrow evaluation if persistent
•  

Conclusion:

This is not a normal result. The pattern most strongly suggests: An active inflammatory condition with immune system involvement,
most likely viral or autoimmune, but hematologic causes must be ruled out.

Part 2

After reviewing the patient’s clinical history and medication details received, the following management plan was proposed

Step1: Urgent imaging of the hip (priority) which detect early necrosis. This critical given her inability to walk.

Step 2: Re-evaluate the diagnosis (Rheumatology referral). The Current treatment is symptomatic only, not disease-modifying.

Order:

ANA, anti-CCP

ESR (along with CRP)

Repeat RF

Possibly HLA-B27 (if indicated)

Goal: identify type of inflammatory arthritis

Step 3: Adjust medications (very important)

Problems with current regimen:

Long-term Prednisone → serious risks:

Osteonecrosis

Infection

Bone loss

Chronic Diclofenac → GI, kidney, CV risks

Recommended approach:

Gradually taper prednisone (do NOT stop abruptly)

Start Disease-Modifying Anti-Rheumatic Drugs (DMARD) therapy if inflammatory arthritis confirmed:

Methotrexate (first-line in many cases)

Use NSAIDs cautiously or switch to safer alternatives if needed

Step 4: Manage hip pathology (depending on imaging)

If avascular necrosis confirmed:

Early stage → conservative + offloading

Advanced stage → orthopedic referral for possible hip replacement

Step 5: Address bone health

Long-term steroids = high fracture risk

Start:

Calcium + Vitamin D

Consider bisphosphonates

Step 6: Evaluate cytopenias

Repeat CBC

Rule out:

• Drug effect
• Chronic disease
• Hematologic disorder

Step 7: Infection screening

Because of:

• High CRP
• Neutropenia
• Steroid use
• Check: Urine, chest, possibly viral tests              

What Should NOT Continue

• Long-term steroids without diagnosis 
• Treating arthritis symptomatically only 
• Ignoring hip pain progression 

Practical Plan (Simple Version)

MRI hip urgently refer to rheumatologist

Taper prednisone carefully start disease-modifying therapy (if confirmed)

Protect bones (Ca + Vit D ± bisphosphonate)

Repeat blood counts + investigate abnormalities

Bottom Line

This patient likely has untreated inflammatory arthritis with a serious complication (possible hip osteonecrosis from steroids).

The priority is:

• Confirm the hip diagnosis (MRI)
• Stop relying on steroids alone
• Start proper disease-modifying treatment

17 April 2026

Prof Kensese Mossanda

Pathologist (Clinical Biochemistry & Molecular Biology)